Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00990158
What this trial is testing

Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability?

Who this might be right for
CoagulationBleedingThrombosis
St. Joseph's Healthcare Hamilton 235
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Large-scale testing (Phase 3)Ended earlyNCT02145598
What this trial is testing

Treatment Optimization in Patients With Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dr. med. Lars-Olof Muegge 85
Testing effectiveness (Phase 2)Study completedNCT01088984
What this trial is testing

Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Who this might be right for
Leukemia
Teva Branded Pharmaceutical Products R&D, Inc. 43
Not applicableStudy completedNCT00538109
What this trial is testing

An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Who this might be right for
Leukemia, Myeloid, Chronic
King Faisal Specialist Hospital & Research Center 8
Not applicableLooking for participantsNCT07035938
What this trial is testing

T-cell Developmental Status in Patients With Malignant Hematological Tumors

Who this might be right for
Hematologic Malignancy
The First Affiliated Hospital of Xiamen University 75
Early research (Phase 1)Ended earlyNCT04060849
What this trial is testing

Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSolid Neoplasm
Fred Hutchinson Cancer Center 10
Not applicableStudy completedNCT04783038
What this trial is testing

Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplant
Mayo Clinic 30
Testing effectiveness (Phase 2)Ended earlyNCT00849251
What this trial is testing

Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
University of Washington 31
Testing effectiveness (Phase 2)Study completedNCT00764231
What this trial is testing

A Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid LeukemiaExerciseFatigue+1 more
Toronto Rehabilitation Institute 40
Early research (Phase 1)Study completedNCT00642031
What this trial is testing

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesLeukemia
Prescient Therapeutics, Ltd. 20
Early research (Phase 1)Study completedNCT00380653
What this trial is testing

Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes

Who this might be right for
LeukemiasMyelodysplastic Syndromes
Cyclacel Pharmaceuticals, Inc. 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660172
What this trial is testing

Ianalumab in Addition to Eltrombopag in Pediatric Patients With Primary ITP Who Failed Corticosteroids.

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Novartis Pharmaceuticals 36
Large-scale testing (Phase 3)Study completedNCT02384122
What this trial is testing

Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias

Who this might be right for
AngiodysplasiaVascular MalformationsGastrointestinal Hemorrhage+1 more
Radboud University Medical Center 62
Testing effectiveness (Phase 2)WithdrawnNCT04230031
What this trial is testing

Phase II Study of Daratumumab Pre-Mobilization and Post-ASCT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT00082537
What this trial is testing

MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)

Who this might be right for
NeutropeniaFever
Merck Sharp & Dohme LLC 100
Early research (Phase 1)Ended earlyNCT04045028
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma
Genentech, Inc. 41
Very early researchUnknownNCT03661554
What this trial is testing

BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
The Pregene (ShenZhen) Biotechnology Company, Ltd. 15
Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Testing effectiveness (Phase 2)Study completedNCT03450057
What this trial is testing

Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Hellenic Society of Hematology 38
Next Page